Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase I and preliminary phase II evaluation of adriamycin (NSC 123127).

× No keyword cloud information.

46 in total

1. Narrowing the embryologic window of the adriamycin-induced fetal rat model of esophageal atresia and tracheoesophageal fistula.

Authors: B Qi; J A Diez-Pardo; C Navarro; J A Tovar
Journal: Pediatr Surg Int Date: 1996-08 Impact factor: 1.827

Review 2. Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors: Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal: Am J Physiol Heart Circ Physiol Date: 2015-09-18 Impact factor: 4.733

3. Adriamycin cardiotoxicity: report of an unusual case with features resembling endomyocardial fibrosis.

Authors: W Fitter; D J deSa; K R Pai
Journal: J Clin Pathol Date: 1981-06 Impact factor: 3.411

Review 4. Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors: V Ashutosh Rao
Journal: Antioxid Redox Signal Date: 2012-10-26 Impact factor: 8.401

5. Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-alpha-tocopheryl acetate or coenzyme Q10 in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q10).

Authors: N Yamanaka; T Kato; K Nishida; T Fujikawa; M Fukushima; K Ota
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

6. [Multidrug chemotherapy of osteogenic sarcoma (author's transl)].

Authors: G Prindull
Journal: Blut Date: 1979-10

7. Distribution of doxorubicin to normal breast and tumour tissue in patients undergoing mastectomy.

Authors: S Stallard; J G Morrison; W D George; S B Kaye
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

Review 8. Pharmacokinetics of anticancer drugs in children.

Authors: W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal: Clin Pharmacokinet Date: 1987-03 Impact factor: 6.447

9. Adriamycin and daunorubicin inhibition of mutant T4 DNA polymerases.

Authors: M F Goodman; M J Bessman; N R Bachur
Journal: Proc Natl Acad Sci U S A Date: 1974-04 Impact factor: 11.205

10. Intra-arterial adriamycin chemotherapy for bladder cancer. Semiselective intra-arterial chemotherapy with compression of the femoral arteries at the time of injection.

Authors: T Uyama; S Moriwaki; M Yonezawa; J Fujita
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333